This is a proof (draft) Hansard, not the final version.
The Parliament has not yet published the final text for this day, so the wording, who said what and the results of divisions may change.
Senate debates Bills
Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026, Therapeutic Goods (Charges) Amendment Bill 2026; In Committee
Anne Ruston SA, Liberal Party, Shadow Minister for Health and Aged Care
7:53 pm
I thank the minister for her response to the amendments, but I have to say it is incredibly disappointing that we're here in absolutely good faith and in the interests of making sure that we have got transparency about something that is as important to Australia as our medicine supply and the ongoing shortages that seem to be constantly repeating themselves. We're not talking about medicine shortages that just happen every now and again; we're talking about more than 420 medications being in short supply in this country right now, as we stand here today.
What we want to do is provide a transparent mechanism in legislation so that we can always be ahead of the game when these shortages are coming down the pipeline. When the minister stands up and says that the government is not going to support this amendment, she is, in effect, saying that the government doesn't want to support transparency and accountability in relation to the supply of medicines to this country. This government doesn't want transparency and accountability when it comes to their actions and their handling of the supply of medicines to this country. Don't forget, we're not talking about aspirin here. In many instances, we're talking about medicines that will save people's lives. If people do not get access to these medicines, some people will die. All we want is transparency and accountability around the process that the government has put in place to make sure that we understand as early as possible that those shortages are likely to occur and to make sure that the consequences and impact of those shortages across the entire Australian health and care network are known to all Australians.
To possibly say that the reason that you can't do this is that it's too onerous for stakeholders—if there is one thing that Australian medical and aged-care stakeholders have told me in the 4½ years that I have been in the role of the shadow minister for health and aged care, it is that the government never consults them. The government tells them what the legislative change or the reform piece is going to be, and then it goes and talks to them later, but it takes no notice of anything that they say. So to suggest that the sector would be resistant to doing reviews or that for them to have their views sought and be consulted with would in any way prevent the government from going ahead with this, I think, is completely and utterly farcical. The one thing that I've always believed is that the best policies are made when, at the time when you develop the policy, you have in the room the people who are going to be impacted by it. That means making sure that you hear the voices of the clinicians, the pharmacists and the aged-care providers—the very people who are administering the medications to Australians. We need to hear what the implications of any changes are for them. We need to listen to the patients as well.
New analysis of 11 years of TGA data by the ABC just this weekend showed that, as of last month, 40 medicines were in critical shortage in this country. More than half of them had been short before. Thirteen had been in critical shortage more than once. These are really important statistics. These aren't one-off events; they are a pattern, and the government has watched that pattern repeat itself time and time again. So we're saying to the government: you've failed in your duty to make sure that you solve the problems of medicine shortages. So what we're saying to you is that we want transparency and accountability. We want you to tell this parliament, on a legislated and regular basis, what is actually going on.
I note the human cost. Bicillin, which is a long-lasting, long acting penicillin, has been in shortage since April 2025, and it's not expected to be back until March 2027. This deals with rheumatic heart disease, which is most prevalent in our Indigenous communities, some of Australia's most vulnerable. This is the sixth recorded shortage of this medicine. How many warnings of a medicine shortage does the minister need before he's prepared to act? There are other examples. Creon, which Australians with cystic fibrosis rely on to digest food, has been short for more than a year. The country's only Q fever vaccine was due to run out within days of that analysis, and that matters enormously to our farmers, shearers and abattoir workers. Other affected medications include a heart imaging agent, a blood pressure injection for late pregnancy, a morning-after pill and a scabies treatment. Australians will remember shortages of EpiPens, ADHD medications, IV fluids and Ozempic.
Experts say our medicine supply chains lack resilience. As I said, we import over 90 per cent of our medicines and we make up just two per cent of the global market. When supply tightens, we're at the end of the queue. In response, the TGA conceded that the government cannot compel companies to supply medicines. It also admitted its own list of long-running shortages is not comprehensive. The ABC actually found shortages missing from the TGA's own archive data, so the government doesn't fully know the scale of the problem, yet it says it lacks the power to fix it. Agree to this amendment, and you will have the transparency to be able to do it.
Progress reported.
No comments